Perrigo (PRGO) Invested Capital (2013 - 2026)
Perrigo (PRGO) posted quarterly Invested Capital of $11.4 million for Q1 2026, down 68.51% year-over-year from $36.2 million in Q1 2025, and down 68.85% quarter-over-quarter from $36.6 million in Q4 2025.
Perrigo (PRGO) Invested Capital (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Invested Capital for 14 consecutive years, with $11.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Invested Capital fell 68.51% year-over-year to $11.4 million; the TTM figure through Mar 2026 stood at $121.0 million (down 87.32% YoY), while the FY2025 annual figure was $36.6 million, up 0.55% from the prior year.
- Invested Capital slipped to $11.4 million in Q1 2026 per PRGO's latest filing, from $36.6 million in the prior quarter.
- Across five years, Invested Capital topped out at $440.8 million in Q2 2024 and bottomed at $4.6 million in Q2 2022.
- Historically, Invested Capital has averaged $128.0 million across 5 years, with a median of $36.6 million in 2025.
- Annual changes were most pronounced in 2022 — Invested Capital tumbled 95.11% — and 2023, when it jumped 1117.13%.
- Perrigo's Invested Capital stood at $36.2 million in 2022, then surged by 1117.13% to $440.6 million in 2023, then plunged by 91.74% to $36.4 million in 2024, then rose by 0.55% to $36.6 million in 2025, then tumbled by 68.85% to $11.4 million in 2026.
- Business Quant data shows PRGO's Invested Capital at $11.4 million in Q1 2026, $36.6 million in Q4 2025, and $36.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 630.00 Mn |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 11.40 Mn |
| Mar 28, 2026 | 11.40 Mn |
| Dec 31, 2025 | 36.60 Mn |
| Sep 27, 2025 | 36.60 Mn |
| Jun 28, 2025 | 36.40 Mn |
| Mar 29, 2025 | 36.20 Mn |
| Dec 31, 2024 | 36.40 Mn |
| Sep 28, 2024 | 440.70 Mn |
| Jun 29, 2024 | 440.80 Mn |
| Mar 30, 2024 | 440.60 Mn |
| Dec 31, 2023 | 440.60 Mn |
| Sep 30, 2023 | 38.10 Mn |
| Jul 1, 2023 | 38.40 Mn |
| Apr 1, 2023 | 38.80 Mn |
| Dec 31, 2022 | 36.20 Mn |
| Oct 1, 2022 | 33.50 Mn |
| Jul 2, 2022 | 30.80 Mn |
| Apr 2, 2022 | 4.60 Mn |
| Dec 31, 2021 | 603.80 Mn |
| Oct 2, 2021 | 629.40 Mn |